Skip to main content

Table 9 Adverse events

From: Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials

Adverse events

No. of studies

Pooled sample size

Heterogeneity

Overall effect

 

T2

I2

P-value

OR [95% CI]

P-value

All side effects

8

1003

4.70

81%

<0.00001

0.35 [0.06, 2.01]

0.24

Hypoglycemia

5

542

0.00

0%

0.77

4.94 [2.03, 11.99]

0.0004

Gastrointestinal upset

5

763

2.27

61%

0.04

0.07 [0.01, 0.37]

0.002